A high CD10 mRNA level was reported for all normal breast tissue (n = 21) as well as 29% of the DCIS (figure 2.A), representing a proportion consistent with the one for CD10 immunostaining. The gene discussed is MME; the disease is ductal breast carcinoma in situ.